Global Anatomical Pathology Market Forecasts to 2026: Increasing Number of Clinical Trials Related to Anticancer Drugs

DUBLIN, November 26, 2021–(BUSINESS WIRE)–The report “Anatomic Pathology Market by Product & Service, Application, End-user, and Region – Global Forecasts to 2026” has been added to ResearchAndMarkets.com’s offer.

The global anatomical pathology market is expected to reach USD 49.1 billion in 2026, up from USD 35.1 billion in 2021, growing at a CAGR of 7%.

The growth of the anatomical pathology market is primarily driven by the high incidence of cancer and other target diseases, cancer screening recommendations, reimbursement availability, and the growing focus on personalized medicine. In addition, emerging economies such as China, India and Brazil are expected to provide significant growth opportunities for players operating in the anatomical pathology market during the forecast period.

The Anatomical Pathology Services segment accounted for the highest growth in the Anatomical Pathology market, by product and service, during the forecast period

Based on product and service, the anatomical pathology market is segmented into services, consumables, and instruments. The anatomical pathology services segment is expected to register the highest CAGR during the forecast period. The growth of this segment is primarily driven by the rapidly growing geriatric population and the increasing incidence of cancer and other chronic diseases.

Disease diagnostics resulted in the highest CAGR

On the basis of application, the anatomical pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment is expected to register the highest CAGR during the forecast period. This can be attributed to the rising geriatric population and the increasing incidence of cancer and other chronic diseases.

Hospital labs accounted for the highest CAGR

Based on the end user, the anatomical pathology market is segmented into hospital labs, clinical labs, and other end users. Hospital labs are expected to record the highest CAGR during the forecast period. An increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals and a growing awareness of early disease diagnosis are key factors contributing to the growth of the segment.

Asia-Pacific: The Fastest Growing Region in the Anatomical Pathology Market

The anatomical pathology market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The Asia-Pacific region offers strong growth opportunities for players in the anatomical pathology market. The presence of emerging economies such as China and India, the large population in APAC countries, the increasing prevalence of chronic diseases, the improvement of living standards, the growing demand for quality medical care, the increasing expenditure on health care and government initiatives, and the increasing awareness about the use of anatomical pathology testing among physicians are the key factors driving the market growth in the Asia-Pacific region.

Research Coverage

This report provides a detailed picture of the Anatomical Pathology market. It aims at estimating the size and future growth potential of the market in various segments such as product and service, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments and key market strategies.

Market dynamics

  • drivers

    • High incidence of cancer and other target diseases

    • Cancer Screening Recommendations

    • Reimbursement Availability

    • Increasing focus on personalized medicine

  • Opportunities

  • Challenges

    • Availability of refurbished products

    • Lack of skilled professionals

    • Product Outages and Recalls

    • Inadequate infrastructure and low awareness in middle and low-income countries

  • Trends

Profiled companies

  • abcam plc

  • Agilent Technologies

  • Amos Scientific Pty. Ltd.

  • Becton, Dickinson and Company

  • Organic SB

  • biogenex

  • Bright Instruments

  • Cell Signaling Technology

  • Cellpath Ltd.

  • Danaher Corporation

  • Diapath SpA

  • F. Hoffman-La Roche Ltd.

  • Histo-Line Laboratories

  • Hologic, Inc.

  • Jinhua Yidi Medical Appliance Co. Ltd.

  • Lupetec

  • medimeas

  • Medite Medical GmbH

  • Merck KGaA

  • Micros Austria

  • Milestone Medical

  • PHC Holdings Corporation

  • RK Scientific Instrument Private Limited

  • Sakura Finetek USA Inc.

  • Slee Medical GmbH

For more information on this report, please visit https://www.researchandmarkets.com/r/9qh8pl

Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20211112605432/en/

Contacts

ResearchAndMarkets.com
Laura Wood, senior press manager
press@researchandmarkets.com
For EST business hours, call 1-917-300-0470
For USA/CAN Toll Free Call 1-800-526-8630
For GMT office hours, please call +353-1-416-8900

Leave a Comment